Overview
Title
Proposed Data Collection Submitted for Public Comment and Recommendations
Agencies
ELI5 AI
The CDC wants to hear what people think about a plan to keep track of some strong germs that can make people sick in hospitals, and they've added three new germs to watch out for. They're asking for opinions by March 10, 2025, to help make the plan better.
Summary AI
The Centers for Disease Control and Prevention (CDC) is seeking public comment on a proposed project called "Pathogens of High Consequence," which evaluates the presence of certain serious diseases in hospitals. As part of this project, three additional diseases—Influenza A (H5), Marburg, and Oropouche—have been added to the data collection form. The updated project aims to help hospitals track these diseases to better prevent and manage outbreaks. Comments from the public must be submitted by March 10, 2025, through the specified methods.
Abstract
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled Pathogens of High Consequence, which assesses the incidence and prevalence of select high consequence pathogens of public health importance in acute care hospitals. In addition to the nine diseases approved for collection, the following three additional diseases are being added to the form: Influenza A (H5), Marburg, and Oropouche.
Keywords AI
Sources
AnalysisAI
The document under review is a notice from the Centers for Disease Control and Prevention (CDC), inviting public comment on a proposed information collection project involving the assessment of certain high-consequence pathogens in acute care hospitals. Titled "Pathogens of High Consequence," the project is notable for adding three diseases—Influenza A (H5), Marburg, and Oropouche—to its data collection form, alongside nine previously approved diseases. Public comments on this proposal are sought by March 10, 2025.
General Summary
The CDC is seeking input on a significant data collection initiative aimed at understanding the prevalence of serious diseases in hospitals across the United States. Through the National Healthcare Safety Network (NHSN), this initiative will gather data to assess the incidence of new and existing patients hospitalized with certain infectious diseases. The project's expansion includes additional diseases of growing concern, necessitating robust data to inform prevention and containment strategies. The notice clarifies that participation is required for healthcare facilities using the NHSN platform, and the data collection process will be facilitated electronically.
Significant Issues or Concerns
Several aspects of this project could raise questions or concerns among stakeholders and the general public:
Cost Management: The document lacks detailed information on the costs involved in the data collection process and how these will be managed. Without this information, it could lead to public concern about potential inefficient use of resources.
Data Utilization Transparency: There's an ambiguity regarding how the collected data will be utilized beyond what is broadly stated. This could lead to calls for greater transparency about the specific applications and benefits of the data.
Data Privacy: The mention of "protected data" requires clarification. It is unclear what type of data will be protected and the measures that will be taken to ensure privacy, which is critical given the sensitive nature of health data.
Implications of Required Participation: The notice suggests that participation is mandatory for healthcare facilities, yet it fails to outline the consequences of non-compliance or how this requirement will be enforced, potentially leading to compliance issues.
Understanding Annual Burden Hours: The document refers to OMB approval for an estimated 111,021 annual burden hours. This technical jargon might be confusing for the public, who may not understand its practical implications or basis.
Broad Impact on the Public
The proposal could significantly impact public health management by providing important data on the spread and control of serious infectious diseases in the country. The addition of new diseases to the tracking system reflects an ongoing commitment to adapting to emerging health threats. By seeking public comment, the CDC also emphasizes its intent to involve various stakeholders in shaping effective health policies and practices.
Impact on Specific Stakeholders
For healthcare facilities, the requirement to participate in this data collection initiative could mean additional administrative actions, potentially leading to increased workload. However, these efforts could also enhance the facilities' ability to manage infectious disease outbreaks more effectively.
For federal and state health departments, the collected data will be crucial in guiding national and local health strategies and preventing the wider spread of infectious diseases.
For members of the public, the initiative promises indirect benefits by potentially reducing the risk of infection and improving overall health safety. However, without a clear understanding of data privacy protection, there may be concerns regarding the security of personal health information.
Overall, the notice signifies an important step in bolstering the country's readiness to tackle high-consequence pathogens, though some areas require further clarification to ensure effective implementation and public reassurance.
Issues
• The document does not provide detailed information regarding the costs associated with the data collection process or how these costs will be managed effectively, potentially leading to concerns about wasteful spending.
• There is ambiguity in understanding exactly how the collected data will be used beyond what is broadly stated, creating potential issues of transparency.
• The document mentions 'protected data' without clearly specifying what type of data will be protected and how privacy will be maintained.
• The document assumes participation is 'required' for healthcare facilities, but does not elaborate on the implications or penalties for non-compliance.
• The phrase 'OMB approval for an estimated 111,021 annual burden hours' might be unclear to the general public regarding its practical implications and how this estimation was conducted.
• The language used to describe the data collection process and the diseases could be complex for a layperson, potentially affecting public understanding and engagement.